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Inflammation or dysbacteriosis-derived lipopolysaccharides (LPS) adversely 
influence the embryonic development of respiratory system. However, the precise 
pathological mechanisms still remain to be elucidated. In this study, we demonstrated 
that LPS exposure caused lung maldevelopment in chick embryos, including higher 
embryo mortality, increased thickness of alveolar gas exchange zone, and 
accumulation of PAS+ immature pulmonary cells, accompanied with reduced 
expression of alveolar epithelial cell markers and lamellar body count. Upon LPS 
exposure, pulmonary cell proliferation was significantly altered and cell apoptosis 
was inhibited as well, indicating a delayed progress of pulmonary development. LPS 
treatment also resulted in reduced CAV-1 expression and up-regulation of Collagen I, 
suggesting increased lung fibrosis, which was verified by Masson staining. Moreover, 
LPS induced enhanced Nrf2 expression in E18 lungs, and the increased reactive 
oxygen species (ROS) production was confirmed in MLE-12 cells in vitro. 
Antioxidant vitamin C restored the LPS induced down-regulation of ABCA3, SP-C 
and GATA-6 in MLE-12 cells. Furthermore, LPS induced activation of NF-κB 
signaling in MLE-12 cells, and the LPS-induced decrease in SP-C expression was 
partially abrogated by blocking NF-κB signaling with Bay-11-7082. Bay-11-7082 
also inhibited LPS-induced increases of ROS and Nrf2 expression. Taken together, 
we have demonstrated that oxidative stress and NF-κB signaling are involved in LPS 
induced disruption of pulmonary cell development in chick embryos. 
 







Lipopolysaccharide(s) (LPS), also known as endotoxins, are components of the cell 
wall in Gram-negative bacteria. The recognition of LPS mediates the rapid activation 
of the intracellular TLR4/MD2 signaling pathway, leading to the release of 
pro-inflammatory mediators and other factors crucial for keeping infection under 
control in physiological conditions [1]. Yet these signaling molecules can also elicit 
an acute and uncontrolled inflammatory response in the animal host that triggers cell 
death. As the major virulence factor of Gram-negative bacteria, LPS is known to 
activate leukocytes in the blood when it is released into the peripheral circulation 
during endotoxaemia [2]. In the lung, alveolar macrophages, alveolar epithelial cells, 
and the TLR4 receptor pathway implement the regulatory mechanisms of the defence 
system. Pulmonary surfactant formation is deemed to be affected by Gram-negative 
bacteria and LPS [3].  
The composition of the intestinal microbiota is closely connected to inflammation, so 
any changes to the microbiota have the potential to affect inflammatory responses [4]. 
Gram-negative bacterium-contaminated food and various dietary components can 
alter the gut microbiota. For example, a high-fat diet increased the proportion of 
Gram-negative bacteria present and the LPS leakage through the intestinal barrier in 
the gut [5].  Furthermore, Poroyko et al. studied the reaction of the microbial 
community to LPS-induced lung inflammation and barrier dysfunction, and proposed 
that the morbid transformation of the microbiota during acute lung injury was 
mediated predominantly by endogenous opportunistic pathogens rather than by 
external infectious agents [6]. The accumulation of LPS in circulating blood 
contributed to cell death in different tissues [7], and such blood-borne LPS can be 
quickly removed under normal physiological conditions. However, the continuing, 
low-grade inflammation or dysbacteriosis can invoke the continuous production of 
LPS and replenishment from dormant bacterial reservoirs [7]. In pregnant women, 
developing embryos are especially vulnerable. Unfortunately, very little has thus far 
been documented regarding the negative effects of LPS at this aspect. Yun et al 
  
demonstrated that differences in bacterial composition in mouse lungs could affect 
lung development and the alveolar structure [8]. Infant respiratory distress syndrome 
is deemed to be due to deficient pulmonary surfactant production, which may result 
from structural immaturity in the lung induced by various pathogenic factors. In this 
study, we would like to investigate the connection between the toxicological effects of 
bacterial component LPS and malformation of the lungs at gestation. 
Lungs, derived from embryonic endoderm at the gastrula stage, contain lower 
respiratory tracts and pulmonary alveoli, which are covered by pulmonary epithelial 
cells. The development of lungs begins from outpouching of the embryonic foregut. 
In the developmental process of lung branching morphogenesis, the lung endoderm 
starts to differentiate into epithelial cell lineages along the proximal-distal axis. The 
proximal progenitor cells develop into the secretory cells, mucosal cells and ciliated 
cells of the lung airway, while the distal progenitor cells develop into type I alveolar 
epithelial (AECI) and type II alveolar epithelial (AECII) cells. Squamous AECI cells 
cover nearly 95% of the alveolar surface and are responsible for gas exchange, while 
AECII cells secrete pulmonary surfactant that reduces alveolar surface tension. AECII 
cells can self-replicate and serve as adult stem cells to differentiate into AECI cells 
during normal homeostatic turnover, or when AECI cells become depleted due to 
injury [9, 10]. Pulmonary reticular and elastic fibres form the bulk of the connective 
tissue in the walls of the alveoli. 
The FGF and Wnt signaling pathways are considered to control lung specification, 
branching and patterning during lung development [11]. FGF signaling, especially 
that involving Fgf9, Fgf10 and Fgfr2 genes, plays an important role in the 
development of endoderm and morphogenesis of the lungs [12-14]. Wnt functions as 
an important signaling molecule during early morphogenesis. GATA binding protein 
6 (GATA-6) is a member of the zinc finger GATA protein family, which is mainly 
expressed in the developing endoderm and the vascular smooth muscle of the lung 
[15]. It is speculated that GATA-6 plays an indispensable role in maintaining the 
balance between the proliferation and differentiation of pulmonary epithelial 
  
progenitor cells during lung development, through modulating Wnt signaling [16]. 
Deficiency of GATA-6 leads to epithelial dysplasia due to the aberrant differentiation 
of epithelial progenitor cells during lung development.  
In this study, we determined that LPS exposure can dramatically affect the 
development of the embryonic chick lungs. Furthermore, the possible pathological 






Materials and Methods 
Chick embryos and manipulation 
Fertilized chicken eggs were obtained from the Avian Farm of the South China 
Agriculture University. The eggs were incubated until the required HH stage in a 
humidified incubator (Yiheng Instrument, Shanghai, China) at 38°C and 70% 
humidity. Starting from E7, either 100µg/ml LPS (Sigma, USA) or simple saline 
(control) was directly injected into the air chamber at the blunt end of the eggs every 
other day, and the embryos were harvested at the desired time points. All embryos 
were photographed using a stereomicroscope (Olympus MVX10, Japan) prior to 
further analysis.  
Morphological and Immunofluorescent staining analysis of embryonic chick lungs 
The fresh lungs were weighted for wet mass right after harvest or dried overnight at 
75°C for dry mass measurement[17]. The fresh lungs were then fixed in 4% 
paraformaldehyde, dehydrated, embedded in paraffin wax and serially sectioned at 5 
µm. Haematoxylin and eosin (H&E), periodic acid–Schiff (PAS) and Masson 
stainings were employed to observe histological pulmonary structure and detect 
glycogen and fibrous tissue. For immunofluorescent staining, lung transverse sections 
were de-waxed in xylene, rehydrated and heated for antigen retrieval. After being 
immersed in 3% hydrogen peroxide for 10 min to block endogenous peroxidase, the 
sections were blocked with 5% inactivated goat serum for 30 min at room temperature 
and incubated with primary antibodies against PCNA (1:300; GeneTex), pHIS3 
(1:200；Santa Cruz), CAV-1 （1:200; Thermo Scientific), AQP5 （1:100; Abcam), 
Collagen І (1:200; Abcam), P65 (1:200; Sigma), Nrf2 (1:20; DSHB) and GATA-6 
(1:300; Abcam), respectively, at 4°C overnight with shaking. The sections were then 
incubated with the corresponding Alexa Fluor 555 or 488 labelled secondary 
antibodies (1:1000; Invitrogen) at room temperature for 2 hours in a dark box. Alexa 
Fluor 488: excitation, 488 nm; emission, 505 to 525 nm; Alexa Fluor 555: excitation, 
543 nm; emission, 560 to 620 nm. All the excitation and gain adjustment were kept 
  
constant during image acquisition in control and LPS treatment, and the sections were 
later counterstained with DAPI (1:1000; Invitrogen) at room temperature for 30 min. 
All the sections were photographed using a fluorescence microscope (Olympus IX50, 
Japan) linked to the NIS-Elements F3.2 software and the objective of all the 
Immunofluorescent staining pictures were 40X.A minimum of 3 randomly-selected 
images from 8 samples were assessed per group per assigned time point. We 
established negative control and background fluorescence  to exclude false 
positives(suplementary1). 
 
Transmission electron microscopy (TEM) 
Embryonic chick lung specimens were fixed with 2.5% glutaraldehyde in 0.1 M PBS 
for 2 hours. The anterior primitive streaks were then dissected and stained with 
osmium tetroxide. The specimens were then embedded in resin, ultrathin-sectioned, 
and examined using a Tecnai G2 Spirit TWIN Transmission Electron Microscope 
(FEI, USA). 
Cell line and manipulation 
MLE-12 cell line was attained from ATCC (American Type Culture Collection, 
CRL-2110, USA) and cultured according to the protocol provided by ATCC. DMEM 
medium and penicillin/streptomycin were purchased from Gibco (NY, USA). Insulin, 
transferrin, sodium selenite, hydrocortisone, β-estradiol, 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), L-glutamine 2 mM (in 
addition to that in the base medium) were purchased from Sigma (MO, USA). The 
cells were seeded in six-well plates (1106 cells/ml) in DMEM  supplemented with 
2% fetal bovine serum (Gibco, Gaithersburg, MD, USA) and cultured in a humidified 
incubator with 5% CO2 at 37°C overnight. Cells were then exposed to 10µg/ml LPS 
using blank medium as a control. When needed, Bay-11-7082 and Vitamin C were 
added to the medium at final concentrations of 10µg/ml, respectively. Cells were 
  
harvested 48 hours later for further analysis. Immunofluorescent staining was 
performed 48 hours later using antibodies against GATA-6 (1:300, Abcam), Nrf2 
(1:200, DSHB), P65 (1:200, Sigma) and SP-C (1:1000, Abcam), respectively. A 
minimum of 8 images per treatment group were assayed. The cells were photographed 
using an inverted fluorescence microscope (Nikon, Ti-U, Japan) linked to the 
NIS-Elements F3.2 software.  
Quantitation of apoptotic cells  
Annexin V-FITC (BD Bioscience, USA) and PI double staining were used to identify 
and quantify apoptotic cells present in the MLE-12 cells and chick embryo lungs. 
Brieﬂy, the lung tissue was digested in 10% fetal bovine serum in Dulbecco’s 
modiﬁed Eagle medium, 6.5 mg/ml DNase I, and 12 mg/ml collagenase I (Roche, 
Indianapolis, IN) (30 min; shaking 200 rpm; 37℃). The cell suspension was strained 
through a 70-mm cell strainer (Fisher Scientiﬁc, Fair Lawn, NJ) and cells were 
collected by centrifugation (500×g; 5 min; 4℃). Cells were resuspended in Geyes 
solution, centrifuged as before, and collected in PBS. the cells were collected and 
resuspended in cold PBS at a density of 1×106 cells/ml and then introduced into 200 
μl of the Annexin V-binding buffer. The samples were then incubated with 2μl 
ﬂuorescein isothiocyanate (FITC)-labeled Annexin V and 2μl PI at room temperature 
for 15min and immediately analyzed by a FACS Calibur ﬂow cytometer (BD, NJ, 
USA). The acquired data were evaluated using FCS-Express software version 3.0 (De 
Novo). 
Cell cycle assay  
Tissues were digested in the same way as quantitation of apoptotic cells .Cultured 
cells were washed twice by centrifugation in phosphate-buffered saline at 4°C, 
1300rpm for 3min. After vortexing gently, the cell suspension was slowly added to 
1ml of 70% ethanol in a 1.5-ml e-tube and stored at −20°C for 1h. Following 
centrifugation at 1300rpm, 4°C for 3min, the pellets were resuspended in 1-ml cold 
phosphate-buffered saline containing RNase A (50μgml−1) and incubated at 37°C, 5% 
  
CO2 for 40min. PI was diluted to 50μgml−1 with distilled water, and transferred to a 
glass tube. The tube was placed on ice and analyzed using a ﬂow cytometer (BD 
FACS Aria USA).  
Measurement of intracellular reactive oxygen species (ROS) 
Intracellular ROS was determined using a non-fluorescent dye DCF-DA 
(2′7-dichlorodihydrofluorescein diacetate) (Sigma-aldrich, USA), which could be 
oxidized by ROS to the fluorescent dye DCF (2,7-dichlorofluorescin). MLE-12 cells 
were seeded and incubated at 37°C and 5% CO2 overnight. The cells were then 
exposed to simple saline or 10µg/ml LPS. When needed, Bay-11-7082 and Vitamin C 
were added to the medium at final concentrations of 10µg/ml, respectively. At the end 
of treatment, the cells were incubated in 10μM DCF-DA for 20 min. The intensity of 
the fluorescence was measured using a BD FACSAria (USA). 
 
TUNEL analysis 
TUNEL staining was performed using an In Situ Cell Death Detection Kit (Roche, 
USA) according to the manufacturer’s instructions. Briefly, sections (4 µm) were 
deparaffinized in xylene, rehydrated in decreasing concentrations of ethanol, 
rehydrated and heated for antigen retrieval. Endogenous peroxidase was blocked in 
3% hydrogen peroxide. Three different dilutions (1 : 7, 1 : 11, and 1 : 16) of terminal 
deoxynucleotidyl transferase (TdT) in reaction buffer (containing a fixed 
concentration of digoxigenin‐labelled nucleotides) were applied to serial sections at 
37 °C for 1 hr before the slides were placed in Stop/Wash buffer for 10 min. 
Following intensive washing, a pre-diluted anti‐digoxigenin peroxidase‐conjugated 
antibody was applied for 30 min. Apoptotic cells were detected after incubation in the 
3,3′‐diaminobenzidine (DAB) chromogen (DAKO, Carpinteria, CA, USA) for 6 min 
and slides were counterstained with Methyl Green (Sigma, St Louis, MO, USA). The 
presence of TUNEL+ cells was determined using the Image Analysis Software 
  
(Olympus, Japan). We evaluated the percentage of TUNEL+ cells relative to the total 







Western blotting was performed in accordance with a standard procedure. Protein 
samples were extracted from lung tissue homogenate or MLE-12 cell lysate using a 
radio-immuno-precipitation assay buffer (RIPA, Sigma, USA) supplemented with 
protease and phosphatase inhibitors, and the protein concentrations were quantified 
using BCA assay. The protein samples were separated by 10% SDS-PAGE and 
transferred onto a PVDF membrane (Millipore, MA, USA). The membrane was 
blocked with 5% non-fat milk and then was incubated with primary antibodies at 4°C 
overnight against P65 (1:1000; Bioworld), SP-C (1:1000; Abcam), AQP5 (1:1000; 
Abcam), GATA-6 (1:1000; Abcam) or ABCA3 (1:1000; Abcam) in TBS buffer, 
respectively. β-actin was used as a loading control (1:3000; Proteintech). After 
incubation with HRP conjugated secondary antibodies (1:3000; EarthOx), the blots 
were developed with the SuperSignalTM West Femto Chemiluminescent Substrate 
(ThermoFisher, Rockford, USA) and Gel Doc™ XR+ System (BIO-RAD, CA, USA). 
The intensity of the bands was analyzed using the Quantity One software (BIO-RAD, 
CA, USA) according to the manufacturer’s instructions. The Western blotting results 
are representative of three independent experiments.  
RNA isolation and qPCR 
Total RNA was isolated from fresh embryonic chick lung tissue or MLE-12 cells 
using the E.Z.N.A® Total RNA Kit (OMEGA, Georgia, USA) according to the 
  
manufacturer’s instructions. First-strand cDNA synthesis and the SYBR® Green 
qPCR assay were performed using the PrimeScriptTM RT Reagent Kit (Takara, Japan). 
All the specific primers used are described in Table 1. The reverse transcription 
reactions were performed in the Bio-Rad S1000TM thermocycler (Bio-Rad, USA). 
qPCR mixture was then incubated at 95°C for a 3 min initial denaturation step 
followed by 40 PCR cycles (95°C for 5s, 60°C for 20 s, and 72°C for 20 s), using the 
ABI 7000 Real Time PCR machines. Corresponding relative mRNA expression was 
calculated by the 2−ΔΔCq method and normalized to β-actin [18]. The qPCR results are 
representative of three independent experiments.  
Data analyses 
Data analyses were performed using Graphpad Prism 5 software package. The results 
are presented as Mean ± SEM. Statistical analyses were performed using one-way 
ANOVA and Student’s t-test. P<0.05 was considered to be statistically significant. 
  
Results 
LPS exposure restricted the morphogenesis of embryonic chick lungs 
In chick embryos, lung morphogenesis takes place before birth in five stages. 
Bronchial epithelial cells start differentiation at E7, and emergence of AECII starts at 
E14 and ends at E18, with the final alveolar maturation occurring postnatally [19]. 
Therefore, starting from E7, chick embryos were exposed to 100µg/ml LPS or simple 
saline (control) every other day via injection into air chambers. LPS treatment 
significantly reduced the survival rate of E18 chick embryos (Figure 1A), and 
LPS-treated embryonic chick lungs appeared smaller (Figure 1B), with significantly 
reduced mass compared to that of control (Figure 1C). The pathological action of LPS 
is facilitated via the TLR4/MD2 complex, which is sequentially regulated by a series 
of adaptor proteins [3]. Hence, we sought to evaluate the TLR4 expression with 
qPCR, and found that LPS exposure dramatically increased TLR4 expression in E18 
lungs (Figure 1D). 
Next, we examined the histological characteristics of embryonic lungs with H&E 
staining. Atrial and infundibular (star) dilation, interatrial septal (arrow) thinning  
and gas exchange zone (bar) narrowing were seen in control lungs, which displayed a 
spongy lung phenotype at E18, and were well prepared for gas exchange at hatching. 
LPS exposure significantly enhanced the thickness of the gas exchange zone and 
induced a less mature and solid lung phenotype (Figure 2A, E). Immature alveolar 
epithelial cells contain abundant glycogen store, which will be converted into 
surfactant phospholipids and disappear upon maturation [20]. PAS staining showed 
that glycogen were gradually reduced during the lung development, but LPS 
significantly increased the PAS+ area compared to control (Figure 2C, F), indicating 
that LPS induced delayed differentiation of pulmonary cells. We further examined the 
lamellar body count, an indicator of AECII development and fetal lung maturity [21], 
using TEM and found that lamellar body count was remarkably decreased upon LPS 
exposure, suggesting an impaired AECII differentiation and maturation (Figure 2B). 
  
Meanwhile, we demonstrated a dramatically suppressed expression of AQP5, an 
AECI marker [22], with immunofluorescent staining in E18 chick lungs (Figure 2D, 
G). Finally, qPCR confirmed that the expressions of AQP5, ABCA3 and SP-C were 
all reduced at the mRNA level in E18 chick lungs upon LPS exposure (Figure 2H). 
These data indicate that exposure to LPS restricted the development of the embryonic 
lungs. 
LPS exposure promoted fibrosis in embryonic chick lungs 
One possible cause of hyperglycaemia-induced thickening of the pulmonary septal 
wall is the activation of fibroblasts and overproduction of extracellular matrix in 
interstitial tissue. To explore this possibility, we carried out immunofluorescent 
staining of CAV-1, a critical regulator of lung fibrosis [23], in E16 and E18 chick 
lungs. The results showed that the expression of CAV-1 was significantly reduced by 
LPS treatment compared to controls in both E16 and E18 lungs (Figure 3A, D). 
Masson staining is routinely used to assess tissue fibrosis, and we observed increased 
Masson staining of E18 chicken lung in the LPS-treated group compared to control 
(Figure 3B). Since the overexpression of type I collagen is a possible hallmark of 
organ fibrosis [24], we also implemented immunofluorescent staining of collagen I in 
E18 chick lungs, and the results showed that collagen I was highly expressed more in 
the LPS-treated lung than in the control (Figure 3C, E). Furthermore, by using qPCR, 
we demonstrated that the expression levels of fibrosis related genes, such as TGF-β1, 
TGF-β2 and Fibronectin 1 were dramatically up-regulated upon LPS exposure (Figure 
3F). All these data indicate that LPS promoted pulmonary fibrosis in the chick lungs.  
LPS exposure modulated cell proliferation and apoptosis in embryonic chick lungs  
Proper cell differentiation and apoptosis are crucial for alveologenesis in the 
developing lungs. To evaluate the proliferation of pulmonary cells, we assessed the 
expression levels of S-phase marker PCNA and M-phase marker pHIS3 in E14 and 
E18 chick lungs. The results showed that, compared to control, both PCNA and 
pHIS3 were reduced upon LPS exposure at E14, but turned to more expression at E18 
  
(Figure 4A, B, C), which suggests that LPS retarded the proliferation progress of 
embryonic lungs. Meanwhile, LPS treatment significantly reduced the numbers of 
TUNEL+ cells in both E14 and E18 chick lungs (Figure 4D, E), indicating that LPS 
inhibited apoptosis in embryonic pulmonary cells.FCM (flow cytometry) shows the 
same results (supplymentary figure 4). To elucidate the mechanism of growth 
inhibition of LPS on MLE-12 cells and chick embryo lungs, we analyzed the cell 
cycle. The results demonstrated that LPS exposure resulted in a significant increase in 
the percentage of cells in the G1 phase indicating the G1 cell cycle arrest 
(Supplementary figure 7A, 7A1). And the same result on E14 chick embryo lungs was 
observed (Supplementary figure 7B, 7B1). These data reveal that LPS exposure 
inhibited the growth of cells by inhibiting cell cycle process. Furthermore,we assayed 
the expression levels of cell cycle related genes in E18 lungs and found that 
expressions of Cyclin A2, Cyclin B1, Cyclin D1, Cyclin E1, Cdk2, Cdk6 and P21 
were all increased in the LPS-treated lungs (Figure 4F). This indicates that 
LPS-induced alterations might be partially attributable to altered expression of cell 
cycle genes.  
Oxidative stress involved in the LPS-induced abnormal development of chick lungs  
We then explored the potential involvement of oxidative stress in LPS-induced 
embryonic lung malformation. The immunofluorescent staining revealed that Nrf2, 
the master regulator of antioxidant responses [25], was significantly up-regulated 
upon LPS exposure in E18 chick lung (Figure 5A, B). MLE-12 is a commonly used 
murine cell line expressing some features of normal AECII [26], and we used it as an 
in vitro model to further verify the connection between oxidative stress and 
LPS-induced abnormal pulmonary cell differentiation. LPS induced an intracellular 
ROS production enhancement, which was partially blunted by the addition of vitamin 
C to the culture medium (Figure 5C). GATA-6 plays a crucial role in regulating 
pulmonary epithelial differentiation during lung development[16], and LPS 
significantly inhibited GATA-6 expression in MLE-12 cells, while it was partially 
restored by vitamin C (Figure 5D, E). Western blotting and qPCR data further 
  
confirmed that LPS induced down-regulation of SP-C, ABCA3 and GATA-6 
expressions, which could be restored by vitamin C (Figure 5F-H). These data 
demonstrated that LPS could induce the oxidative stress, which subsequently led to 
the restriction to embryonic lung development. 
Activation of NF-κB pathway contributed to LPS-induced abnormal differentiation 
of pulmonary cells  
It has been known that the activation of NF-κB is of central importance in 
inflammation and immunity, cell development, growth and survival[27], we 
demonstrated that LPS induced activation of NF-κB signaling in MLE-12 cells. Upon 
LPS exposure, up-regulation of IL6, IL8 and TNF-α expression was observed and this 
effect was abrogated by the addition of IκB/IKK inhibitor Bay-11-7082 (Figure 6C). 
Meanwhile, LPS induced P65 translocation from cytoplasm into nucleus, which was 
also suppressed by Bay-11-7082 (Figure 6A). Western blot further confirmed that 
LPS significantly increased both p65 and phosphorylated p65 levels, and this effect 
was abolished upon the application of Bay-11-7082 (Figure 6D, E). Moreover, LPS 
induced reduction of SP-C in MLE-12 cells, which could be partially restored by 
blocking NF-κB signaling with Bay-11-7082 (Figure 6B, F). These data demonstrated 
that NF-κB signaling involved in LPS-induced disruption of pulmonary cell 
differentiation.  
Although the exact mechanisms still under debate, numerous reports indicate that 
crosstalk between NF-κB and oxidative stress plays inhibitory or stimulatory roles in 
various cellular processes[28]. In our study, we found that LPS induced ROS 
elevation in MLE-12 cells could be partially abrogated by blocking NF-κB signaling 
with Bay-11-7082 (Figure 7A, B). And the LPS induced Nrf2 expression 
enhancement was partially abrogated by Bay-11-7082 as well (Figure 7D, C). 
Furthermore, qPCR data showed that the expressions of Nrf2 and its target genes, 
such as NQO-1, HO-1, and SOD-1, rose with LPS exposure, and fell in the presence 
  
of Bay-11-7082. Meanwhile, Keap-1, an Nrf2 repressor protein, showed an inverse 
pattern (Figure 7E). 
Taken together, our results imply that LPS activated NF-κB signaling could affect 
cellular oxidative stress level, which suppresses GATA-6 expression and interferes 
with the differentiation of pulmonary epithelial cells. 
  
Discussion 
The microbial infection of placental tissues frequently causes unpleasant outcomes in 
pregnancy, including preterm birth, neonatal morbidity and mortality [29]. Clinical 
observations indicate that fetal inflammation is beneficial to preterm lungs and 
reduces incidence of RDS, while it may increase lung BPD on the other hand [30]. 
Yun et al demonstrated that differences in bacterial composition in mouse lungs could 
affect lung development and the alveolar structure [8]. Gao et al. reported that 
maternal exposure to LPS postponed the morphological maturation of the rat lung, 
through altering the expression of genes implicated in alveologenesis [31]. Actually, 
very little has been documented regarding the adverse effects of LPS exposure on 
embryonic lung development, especially from early embryonic stages. Here, we found 
a disruptive influence of LPS exposure on lung development in early stage chick 
embryos, which manifested as higher mortality rates of E18 embryos (Figure 1A) and 
thicker zones of pulmonary gas exchange (Figure 2A, E). Glycogen is the substrate 
for surfactant phosphatidylcholine synthesis in AECII [32], and it is abundant in 
immature alveolar epithelial cells and disappears upon cell maturation. The increased 
PAS staining following LPS exposure (Figure 2C, F) might indicate the misguidance 
of pulmonary development and/or dysfunction of AECII.  
Proliferation and apoptosis participate in lung development during both the prenatal 
and postnatal periods [33]. At the embryonic stage, branching morphogenesis begins 
with extensive proliferation of epithelial and mesenchymal cells, but no epithelial 
apoptosis [34]. At the pseudoglandular stage, the bronchial airway tree is established 
by repeated dichotomous branching. Pulmonary progenitor cells start to differentiate, 
while epithelial apoptosis still does not occur [35, 36]. At the canalicular stage, 
respiratory bronchioli appear, interstitial tissue decreases, AECII cells differentiate 
into AECI cells, and the apoptosis of interstitial tissue contributes to mesenchymal 
involution and thinning of the alveolar septa. Meanwhile, apoptosis of epithelial cells 
is increased [35-39]. At the saccular stage, terminal airways widen to form saccules, 
the interstitium between airspaces thins, the vascular network expands, and epithelial 
  
cell apoptosis increases further [35-39]. At the alveolar stage, there is extensive 
alveolar septation, an increase in the number of alveoli, further thinning of the 
epithelial-endothelial barrier, and then a transient increase in apoptosis at birth 
followed by continuous proliferation of epithelial cells [40, 41]. In this study, we 
revealed that cell proliferation was inhibited upon LPS exposure at E14. However, 
even though continuing decreasing within the same group at E18, the proliferation 
level in LPS treated lungs was significantly higher than that in control, which was 
opposite to that at E14 (Figure 4A-C), implying differential susceptibilities of 
pulmonary progenitor cells towards LPS at different stages of development. The 
LPS-induced inhibition of cell apoptosis (Figure 4D, E) disrupted 
apoptosis-modulated remodeling alveologenesis in the developing lung. The increased 
expression of cell cycle-related genes further verified our initial speculations (Figure 
4F). Cell apoptosis during lung development might be primarily regulated by the 
apoptosis factor TGF-β and the anti-apoptotic factors IGF-1 and NO, in addition to 
other apoptosis-related proteins [33]. 
LPS-induced inflammatory responses often lead to fibrosis. Besides, when AECII 
cells proliferate and differentiate into AECI cells, many fibrosis-associated cytokines 
tend to be secreted. Meanwhile, the transdifferentiation of myofibroblasts proceeds, 
ultimately further promoting lung fibrosis [42]. It has also been reported that 
pulmonary epithelial cell transformation to mesenchymal cells (EMT) promotes 
fibrosis, because the transformed cells eventually differentiate into fibrous connective 
tissue, leading to heavy interstitial fibrous tissue deposition [43]. CAV-1 is an 
endothelial marker and can be used as an indicator for fetal lung development [44]. In 
this study, we found that LPS exposure inhibited CAV-1-labelled cell maturation in 
embryonic chick lung (Figure 3A, D), indicating a suppression of pulmonary cell 
differentiation. Meanwhile, LPS enhanced the expression of Collagen I as well as 
fibrosis related gene expression (Figure 3C,E,F), supporting the notion of 
LPS-mediated induction of fibrosis in the developing lung.  
  
Nrf2-Keap-1 signaling pathway is of great importance in protection against oxidative 
damage triggered by inflammation and injury. LPS induced significant increase in 
Nrf2 expression in E18 lungs (Figure 5A, B), and we utilized MLE-12 cells to further 
investigate its possible role in LPS induced lung alteration in vitro. LPS stimulated the 
elevation of ROS production in MLE-12 cells (Figure 5C), and the expressions of 
ABCA3 and SP-C were inhibited at the same time (Figure 5F-H). Meanwhile, 
scavenging ROS with vitamin C alleviated this inhibition, indicating oxidative stress 
may involve in LPS induced lung mal-development. Zhang et al. reported that 
GATA-6 and Wnt signaling co-ordinately regulated the expansion of stem/progenitor 
cells and epithelial cell differentiation during both lung development and regeneration 
[16], and LPS significantly inhibited GATA-6 expression in MLE-12 cells, which was 
also reversed by vitamin C (Figure 5F-H). It’s possible that LPS induced the oxidative 
stress, which subsequently led to the restriction to embryonic lung development. 
NF-kB signaling is involved in the pathogenesis of lung fibrosis, and is frequently 
activated in response to LPS [45, 46]. P65 is one of the five components of NF-κB 
and it enters into nucleus upon the activation of NF-κB signaling [47]. Here, we 
observed the nuclear translocation and phosphorylation of P65 in MLE-12 cells in 
response to LPS exposure, and this effect was abrogated by the NF-κB signaling 
inhibitor, Bay-11-7082 (Figure 6A,D,E). Moreover, LPS exposure inhibited SP-C 
expression in MLE-12 cells, and Bay-11-7082 could appreciably alleviate this 
suppressive effect (Figure 6B, F). These data indicate the involvement of NF-κB 
signaling in LPS-induced pulmonary fibrosis.  
It is reported that crosstalk between NF-κB and oxidative stress involves in the 
regulation of various cellular processes [28]. LPS can generate ROS through the 
activation of pro-inflammatory cytokines, such as TNF-α, IFN-γ, IL-6 and IL-12 [48, 
49], which in turn can result in significant cell damage or apoptosis in embryos [50, 
51].Likewise, we also found the excessive production of pro-inflammatory cytokines 
(Figure 6C) and ROS from MLE-12 cells exposed to LPS (Figure 7A), and again the 
enhancement of ROS in presence of LPS was partially repressed by blocking NF-κB 
  
signaling (Figure 7A, B), further indicating the involvement of NF-κB signaling. 
Furthermore, the blocking of NF-κB signaling revered the LPS induced alteration of 
Nrf2-Keap-1 signaling pathway, indicating the crosstalk between these two pathways 
in LPS induced lung mal-development. 
There indeed are some reports which demonstrated the present of microbial flora in 
the mother's vagina, intestines, amniotic fluid and placenta. LPS disrupts the mother's 
bacterial composition which can cause inflammatory reactions  and affects fetus’s 
development, and bacterial colonization is most common in fetus’s membrane 
infection, amniotic fluid and/or premature delivery. However, the mechanism of LPS 
developmental toxicity is still not clear. In this study, we demonstrated that LPS 
induced disruption of pulmonary cell development in chick embryos with the 
involvement of oxidative stress and NF-κB signalling, which may provide some 
information to solve the problem mentioned-above.We demonstrated the LPS-induced 
lung malformation in embryonic chick and it is attributable to at least several 
mechanisms. Firstly, LPS exposure interferes with the cell cycle of pulmonary 
precursor cells, and inhibits apoptosis. Secondly, LPS exposure clearly promotes lung 
fibrosis. NF-κB signaling plays an indispensable role in LPS-induced disruption of 
lung development via mutual interactions with oxidative stress. All of these 
phenomena adversely affect the differentiation of pulmonary epithelial cells through 
the alteration of GATA-6 expression. As a consequence, the dysfunction of the 
signaling pathways described above leads to aberrant alveolar development in the 
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Figure 1. LPS induced macroscopic alteration in chick embryonic lungs. (A) LPS exposure 
significantly reduced survival rate of E18 chick embryos compared to controls. (B) The morphological 
appearance of embryonic chick lungs at E14, E16 and E18, and LPS induced smaller sized changes. (C) 
LPS exposure significantly reduced the wet and dry mass of embryos and lungs. (D) The qPCR data 
show LPS induced significantly up-regulated TLR4 expression at mRNA level in E18 chick lungs. *P< 
0.05. **P < 0.01. Scale bar = 200μm. 
 
Figure 2. LPS induced microscopic alteration in chick embryonic lungs. (A, E): H&E staining was 
performed on transverse sections of chick lungs. The alveolar wall and gas exchange zone are indicated 
with arrows and line segments, respectively.  LPS increased gas exchange zone thickness, and control 
lungs display a more mature spongy phenotype at E18. (B): The representative TEM images of E18 
chick lungs shows lamellar bodies at multiple spherical particles, ranging from 500nm to 5 μm. LPS 
significantly reduced LB count. (C, F): PAS staining was performed on transverse sections of 
embryonic chick lungs. LPS induced more PAS+ areas relative to total areas in embryonic chick lungs. 
(D, G): In immunofluorescent staining of E18 chick lungs, red color shows AQP5 and blue color shows 
DAPI staining, respectively. The far right panel indicates the dotted squares with higher magnification. 
LPS significantly reduced AQP5+ cells in E18 chick lungs. (H): qPCR data show LPS significantly 
induced down-regulation of AQP5, ABCA3 and SP-C expression at mRNA level in E18 lungs. *P< 
0.05. **P < 0.01 .Scale bars = 50μm.  
 
  
Figure 3. LPS promoted fibrosis in embryonic chick lungs. (A, D): In immunofluorescent staining 
of chick lungs, red color shows CAV-1 and blue color shows DAPI staining, respectively. The far right 
panel indicates the dotted squares of the merged images with higher magnification. LPS induced 
down-regulation of CAV-1 in E16 and E18 chick lungs. (B): LPS increased Masson staining in E18 
chick lungs. The lower panel indicates the dotted squares with higher magnification. (C, E): In 
immunofluorescent staining of E18 chick lungs, red color shows Collagen I and blue color shows 
DAPI staining, respectively. The far right panel indicates the dotted squares of the merged images with 
higher magnification. LPS induced more expression of Collagen I in E18 chick lungs. (F): qPCR data 
show LPS-induced up-regulation of TGF-β2, TGF-β1 and Fibronectin-1 gene expression in E18 chick 
lungs. *P< 0.05. **P < 0.01. Scale bars = 50 μm. 
 
Figure 4. LPS modulated cell proliferation and apoptosis in embryonic chick lungs. (A, B, C): In 
immunofluorescent staining of chick lungs, red color shows PCNA, green color shows pHIS3 and blue 
color shows DAPI staining, respectively. The far right panel indicates the dotted squares of the merged 
images with higher magnification. Compared to control, PCNA and pHIS3 expression were 
down-regulated in E14, while up-regulated in E18 chick lungs upon LPS exposure, respectively. (D, 
E): TUNEL staining of E14 and E18 chick lungs, respectively. The right panels indicate the dotted 
squares with higher magnification. LPS reduced TUNEL+ cells in E14 and E18 chick lungs, 
respectively. (F): qPCR data show LPS induced up-regulation of cell cycle related gene expressions in 
E18 lungs. *P< 0.05. **P < 0.01. Scale bars = 50 μm. 
 
Figure 5. Oxidative stress involved in LPS-induced abnormal development of chick lungs. (A, B): 
In immunofluorescent staining of E18 chick lungs, red color shows Nrf2 and blue color shows DAPI 
staining, respectively. The far right panel indicates the dotted squares of the merged images with higher 
magnification. LPS induced a dramatic increase in Nrf2 expression in E18 chick lungs. (C): Flow 
cytometry data show intracellular ROS production in MLE-12 cells was significantly increased by 
LPS. (D, E): In immunofluorescent staining of MLE-12 cells, red color shows GATA-6 and blue color 
shows DAPI staining, respectively. LPS significantly down-regulated GATA-6 expression. (F, G): 
Western blot shows LPS-induced decrease in protein expression of SP-C, ABCA3 and GATA-6 in 
  
MLE-12 cells. (H): qPCR data show LPS down-regulated mRNA expression of ABCA3, SP-C and 
GATA-6 in MLE-12 cells. All these effects were reversed with vitamin C. *P< 0.05. **P < 0.01. Scale 
bars = 50 μm. 
 
Figure 6. Activation of NF-κB pathway contributed to LPS-induced abnormal differentiation of 
pulmonary cells. (A): In immunofluorescent staining of MLE-12 cells, red color shows P65 and blue 
color shows DAPI staining, respectively. The higher magnification images are shown at right upper 
corners. LPS induced P65 nuclear translocation. (B, F): In immunofluorescent staining of MLE-12 
cells, red color shows SP-C and blue color shows DAPI staining, respectively. LPS induced 
down-regulation of SP-C expression. All these effects were restored with NF-κB inhibitor Bay-11-7082. 
(C): qPCR data show LPS-induced expression of IL-8, IL-6 and TNF-ɑ at mRNA level in MLE-12 
cells. (D, E): Western blotting shows increased protein expression of P65, phospho-P65 in MLE-12 
cells upon LPS exposure. *P< 0.05. **P < 0.01. Scale bars = 50 μm. 
Figure 7. NF-kB signaling modulated ROS in LPS induced alveolar epithelial mal-differentiation. 
(A, B): Flow cytometry data and merged image show LPS-induced ROS elevation in MLE-12 cells 
was abolished with Bay-11-7082. (D, C): In immunofluorescent staining of MLE-12 cells, red colour 
stands for Nrf2 and blue colour stands for DAPI staining, respectively. The higher magnification 
images are shown at the right upper corners. LPS-induced increase in Nrf2 expression was partially 
blocked with Bay-11-7082. (E): qPCR data show LPS induced alteration of oxidative stress related 
genes in MLE-12 cells, which were revered with Bay-11-7083. *P< 0.05. **P < 0.01. Scale bars = 50 
μm. 
 
 
